Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Seong Hoon Shin"'
Autor:
Eun Joo Kang, Yun-Gyoo Lee, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Jii Bum Lee, Jung Hye Kwon, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 1, Pp 190-200 (2022)
Background/Aims Treatment decisions for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are complicated, and multi-modal treatments are usually indicated. However, it is challenging for older patients to complete treatments. Thus, w
Externí odkaz:
https://doaj.org/article/30fe2a84c96840ca8dfdadcdd18104a1
Autor:
Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hyo Jung Kim, Hwan Jung Yun
Publikováno v:
Cancers, Vol 15, Iss 2, p 471 (2023)
We aimed to compare treatment modalities and outcomes by gender in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC). We characterized the sex-specific differences and compared the overall survival (OS) between male and
Externí odkaz:
https://doaj.org/article/e769245ffe7340be8603e1795b8ec92c
Autor:
Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Jung Hye Kwon, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background By investigating treatment patterns and outcomes in locally advanced head and neck squamous cell carcinoma (LA-HNSCC), we aimed at providing valuable insights into the optimal therapeutic strategy for physicians in real-world prac
Externí odkaz:
https://doaj.org/article/288ade2c85504d48ab704fc86dc4f56f
Autor:
Hye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, Seung Tae Kim, Ilhwan Kim, Young Joo Min, Seong Hoon Shin, Sung Yong Oh, Gyeong-Won Lee, Ji Hyun Lee, Jun Ho Ji, Seok Jae Huh, Suee Lee
Publikováno v:
Cancers, Vol 14, Iss 14, p 3440 (2022)
Background: With the development of immunology, immune checkpoint inhibitors (ICIs) have been widely used in various cancer treatments. Although some patients can benefit from ICIs, other patients have no response to ICIs or suffer from hyperprogress
Externí odkaz:
https://doaj.org/article/50f72d2ee7614efbbda2965162230bee
Autor:
Soo-Mee Bang MD, PhD, Jin-Hyoung Kang MD, PhD, Min Hee Hong MD, PhD, Jin-Seok Ahn MD, PhD, So Yeon Oh MD, PhD, Jin Ho Baek MD, PhD, Yoon Ji Choi MD, PhD, Seong Hoon Shin MD, PhD, Young-Joo Kim MSN, Ha-Yeong Gil MS, Hyung-Eun Park MD, Juneyoung Lee PhD, Eun-Lyeong Park MS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
This study assessed epidemiologic data and clinical outcomes, including venous thromboembolism (VTE) recurrence and bleeding events, in patients with cancer-associated VTE, and assessed factors associated with clinical outcomes. Data were extracted f
Externí odkaz:
https://doaj.org/article/4cf4a402f661465db74f5cd782853cab
Publikováno v:
Kosin Medical Journal, Vol 32, Iss 2, Pp 170-178 (2017)
ObjectivesThe addition of bevacizumab to standard chemotherapy has been improved survival outcomes in patients with metastatic colorectal cancer. However, the combination of bevacizumab with oxaliplatin-based chemotherapy as first-line treatment show
Externí odkaz:
https://doaj.org/article/932c89e85a294044aa9e8dbaaccdec35
Publikováno v:
Kosin Medical Journal, Vol 31, Iss 2, Pp 122-133 (2016)
Abstract Objectives The both values of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) were reported as indexes of systemic inflammation and readily available and inexpensive prognostic markers in patients with solid cancer. The
Externí odkaz:
https://doaj.org/article/e4d9012d5e9a43d4b492c165318e1614
Autor:
In Gyu Hwang, Minsuk Kwon, Jin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, Jin Young Kim, Su-Jin Koh, Yoon Ho Ko, Seong Hoon Shin, Soojung Hong, Tae-Yong Kim, Sun Young Kim, Hyun Jung Kim, Hyo Jung Kim, Myung Ah Lee, Jung Hye Kwon, Yong Sang Hong, Kyung Hee Lee, Sung Hwa Bae, Dong-Hoe Koo, Jee Hyun Kim, In Sook Woo
Publikováno v:
Cancers, Vol 13, Iss 2, p 331 (2021)
Old age alone does not reflect an intolerability to chemotherapy. However, upfront dose reduction (UDR) of the first cycle of first-line palliative chemotherapy has sometimes been chosen by physicians for older adults with metastatic cancer due to co
Externí odkaz:
https://doaj.org/article/9fe676cac703405eb0a7fdb29dd42258
Autor:
In Cheol Hwang1, Seong Hoon Shin2 ssh1533@daum.net, Youn Seon Choi3 younseon@korea.ac.kr, Myung Ah Lee4, DaeKyun Kim5, Kyung Hee Lee6
Publikováno v:
Journal of Hospice & Palliative Care. Mar2024, Vol. 27 Issue 1, p45-49. 5p.
Autor:
Jiyun Lee, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Seyoung Seo, Sung‐Bae Kim, Ji‐Won Kim, Keun‐Wook Lee, Eun Joo Kang, Ju Won Kim, Yoon Ji Choi, Byoung‐Yong Shim, Ho‐Jung An, Lee Chun Park, Seong Hoon Shin, Jae‐Joon Kim, So Yeon Oh, Min Kyoung Kim, Myung‐Ju Ahn
Publikováno v:
Cancer.